These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 30801265)
1. Circulating microRNAs in adrenal tumors. Igaz P Curr Opin Endocrinol Diabetes Obes; 2019 Jun; 26(3):155-159. PubMed ID: 30801265 [TBL] [Abstract][Full Text] [Related]
2. MiR-34a and miR-483-5p are candidate serum biomarkers for adrenocortical tumors. Patel D; Boufraqech M; Jain M; Zhang L; He M; Gesuwan K; Gulati N; Nilubol N; Fojo T; Kebebew E Surgery; 2013 Dec; 154(6):1224-8; discussion 1229. PubMed ID: 24238045 [TBL] [Abstract][Full Text] [Related]
3. Analysis of circulating microRNAs in adrenocortical tumors. Szabó DR; Luconi M; Szabó PM; Tóth M; Szücs N; Horányi J; Nagy Z; Mannelli M; Patócs A; Rácz K; Igaz P Lab Invest; 2014 Mar; 94(3):331-9. PubMed ID: 24336071 [TBL] [Abstract][Full Text] [Related]
4. MicroRNA Expression Profiling in Adrenal Myelolipoma. Decmann A; Perge P; Nyíro G; Darvasi O; Likó I; Borka K; Micsik T; Tóth Z; Bancos I; Pezzani R; Iacobone M; Patócs A; Igaz P J Clin Endocrinol Metab; 2018 Sep; 103(9):3522-3530. PubMed ID: 29982598 [TBL] [Abstract][Full Text] [Related]
5. Liquid biopsy for the assessment of adrenal cancer heterogeneity: where do we stand? Perge P; Nyirő G; Vékony B; Igaz P Endocrine; 2022 Sep; 77(3):425-431. PubMed ID: 35552979 [TBL] [Abstract][Full Text] [Related]
7. Evaluation and diagnostic potential of circulating extracellular vesicle-associated microRNAs in adrenocortical tumors. Perge P; Butz H; Pezzani R; Bancos I; Nagy Z; Pálóczi K; Nyírő G; Decmann Á; Pap E; Luconi M; Mannelli M; Buzás EI; Tóth M; Boscaro M; Patócs A; Igaz P Sci Rep; 2017 Jul; 7(1):5474. PubMed ID: 28710381 [TBL] [Abstract][Full Text] [Related]
8. [Pathogenic and diagnostic roles of microRNAs in adrenocortical tumours]. Nagy Z; Decmann Á; Perge P; Igaz P Orv Hetil; 2018 Feb; 159(7):245-251. PubMed ID: 29429354 [TBL] [Abstract][Full Text] [Related]
9. Analysis of circulating extracellular vesicle-associated microRNAs in cortisol-producing adrenocortical tumors. Perge P; Decmann Á; Pezzani R; Bancos I; Fassina A; Luconi M; Canu L; Tóth M; Boscaro M; Patócs A; Igaz P Endocrine; 2018 Feb; 59(2):280-287. PubMed ID: 29299796 [TBL] [Abstract][Full Text] [Related]
10. Serum inhibin pro-αC is a tumor marker for adrenocortical carcinomas. Hofland J; Feelders RA; van der Wal R; Kerstens MN; Haak HR; de Herder WW; de Jong FH Eur J Endocrinol; 2012 Feb; 166(2):281-9. PubMed ID: 22127493 [TBL] [Abstract][Full Text] [Related]
11. Comparison of plasma and urinary microRNA-483-5p for the diagnosis of adrenocortical malignancy. Decmann A; Bancos I; Khanna A; Thomas MA; Turai P; Perge P; Pintér JZ; Tóth M; Patócs A; Igaz P J Biotechnol; 2019 May; 297():49-53. PubMed ID: 30940435 [TBL] [Abstract][Full Text] [Related]
12. The neutrophil-to-lymphocyte ratio (NLR) predicts adrenocortical carcinoma and is correlated with the prognosis. Mochizuki T; Kawahara T; Takamoto D; Makiyama K; Hattori Y; Teranishi JI; Miyoshi Y; Yumura Y; Yao M; Uemura H BMC Urol; 2017 Jun; 17(1):49. PubMed ID: 28662713 [TBL] [Abstract][Full Text] [Related]
13. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis. Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168 [TBL] [Abstract][Full Text] [Related]
14. Circulating Fascin 1 as a Promising Prognostic Marker in Adrenocortical Cancer. Cantini G; Fei L; Canu L; De Filpo G; Ercolino T; Nesi G; Mannelli M; Luconi M Front Endocrinol (Lausanne); 2021; 12():698862. PubMed ID: 34248854 [TBL] [Abstract][Full Text] [Related]
15. MicroRNAs in adrenal tumors: relevance for pathogenesis, diagnosis, and therapy. Igaz P; Igaz I; Nagy Z; Nyírő G; Szabó PM; Falus A; Patócs A; Rácz K Cell Mol Life Sci; 2015 Feb; 72(3):417-428. PubMed ID: 25297921 [TBL] [Abstract][Full Text] [Related]
16. [Adrenal cortical carcinoma. Progress in diagnosis, clinical and genetic features]. Gasińska T; Pietrasik L; Kulawik G Pol Arch Med Wewn; 2005 Sep; 114(3):901-5. PubMed ID: 16708566 [No Abstract] [Full Text] [Related]
17. Next-generation sequencing reveals microRNA markers of adrenocortical tumors malignancy. Koperski Ł; Kotlarek M; Świerniak M; Kolanowska M; Kubiak A; Górnicka B; Jażdżewski K; Wójcicka A Oncotarget; 2017 Jul; 8(30):49191-49200. PubMed ID: 28423361 [TBL] [Abstract][Full Text] [Related]
18. 5th International ACC Symposium: An Outlook to Current and Future Research on the Biology of Adrenocortical Carcinoma: Diagnostic and Therapeutic Applications. Lalli E; Sasano H Horm Cancer; 2016 Feb; 7(1):44-8. PubMed ID: 26666256 [TBL] [Abstract][Full Text] [Related]
19. Future Directions in Diagnosis, Prognosis and Disease Monitoring of Adrenocortical Carcinoma: Novel Non-Invasive Biomarkers. Cheng Y; Kou W; Zhu D; Yu X; Zhu Y Front Endocrinol (Lausanne); 2021; 12():811293. PubMed ID: 35178030 [TBL] [Abstract][Full Text] [Related]
20. Expression Patterns of MOTS-c in Adrenal Tumors: Results from a Preliminary Study. Kamiński K; Blatkiewicz M; Szyszka M; Olechnowicz A; Komarowska H; Klimont A; Wierzbicki T; Karczewski M; Ruchała M; Rucinski M Int J Mol Sci; 2024 Aug; 25(16):. PubMed ID: 39201408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]